Morrison & Foerster is a proud long-term platinum sponsor of the Chinese-American Bio/Pharmaceutical Society and its annual BioPacific Conference. This is the flagship event to bring scientists, executives, and biopharmaceutical professionals from the Pacific Rim countries together to discuss the latest advances in the world of life sciences, the unprecedented challenges and promises facing the industry, and the breathtaking developments and opportunities in Asia/Pacific countries.
Partners Janet Xiao and Chuck Comey will participate in an engaging virtual panel conversation on IP Considerations and Investment trends for Life Sciences.
In addition, FDA partner Bethany Hills will lead a breakout room discussion with associate KB Do addressing Effective Use of Science in the FDA Regulatory Process.
11:20 A.M. – 12:00 P.M.
Panel Discussion 1: IP Considerations and Investment trends for Life Sciences This session will cover intellectual property considerations for life science transactions and stories of investment in new technologies. Options to structure a new company will be discussed. Moderator: Janet Xiao, PhD, JD, Partner, Head of MoFo’s China Life Sciences, Morrison & Foerster LLP Panelists: Chuck Comey, Partner, Morrison & Foerster LLP Sean Cao, PhD, MBA, Managing Director, the CBC Group Neil Desai, PhD, Founder & CEO, AADI
12:00 P.M. – 12:30 P.M.
Breakout room talks Room 1: Effective Use of Science in the FDA Regulatory Process Bethany Hills, PhD, Partner, Morrison & Foerster LLP Keunbong (KB) Do, Associate, Morrison & Foerster LLP